Elvina Almuradova, RAS Mutations in mCRC

Elvina Almuradova: Science Progresses, but If Patients Can’t Access It, We Fail

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on X:

“Science progresses, but if patients can’t access it, we fail. We must bridge the gap between innovation and reality.”

Elvina Almuradova: Science Progresses, but If Patients Can’t Access It, We Fail

More posts featuring Elvina Almuradova.